Avid Bioservices Earnings Preview
Avid Bioservices (NASDAQ: CDMO) will be releasing its next round of earnings this Tuesday, September 01. For all of the relevant information, here is your guide for Tuesday's Q1 earnings announcement.
Earnings and Revenue
Analysts are predicting Avid Bioservices will report a loss of $0.07 per share on revenue of $16.50 million. Avid Bioservices's loss in the same period a year ago was $0.08 per share. Quarterly sales came in at $15.25 million. The Wall Street estimate would represent a 12.5% increase in the company's earnings per share. Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter
Q4 2020
Q3 2020
Q2 2019
Q1 2019
EPS Estimate
-0.16
-0.04
-0.05
-0.03
EPS Actual
-0.11
-0.06
-0.03
-0.08
Revenue Estimate
8.50 M
15.42 M
14.25 M
14.36 M
Revenue Actual
12.55 M
13.59 M
18.31 M
15.25 M
Stock Performance
Over the last 52-week period, shares are up 24.56%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Avid Bioservices is scheduled to hold the call at 16:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/64ateurd
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
